Related Experiment Video
Updated: Oct 22, 2025

Sequence-specific and Selective Recognition of Double-stranded RNAs over Single-stranded RNAs by Chemically Modified Peptide Nucleic Acids
Published on: September 21, 2017
Structure-based design of antisense oligonucleotides that inhibit SARS-CoV-2 replication
Yan Li1,2, Gustavo Garcia3, Vaithilingaraja Arumugaswami3,4
1Department of Biological Chemistry, David Geffen School of Medicine, University of California, Los Angeles, CA 90095, U.S.A.
New 3D-ASOs target SARS-CoV-2 RNA structures, enhancing drug design. This structure-based approach improves antisense oligonucleotide (ASO) therapy for viral infections and beyond.
Area of Science:
- Biochemistry
- Molecular Biology
- Drug Discovery
Background:
- Antisense oligonucleotides (ASOs) are RNA-targeting drugs.
- Current ASO design relies on Watson-Crick base pairing.
- RNA secondary structures can impede ASO binding and efficacy.
Approach:
- Developed a structure-based ASO design method using 3D structural templates.
- Engineered 3D-ASOs to interact with target RNA structures via tertiary interactions.
- Applied the method to target severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).
Key Points:
- 3D-ASOs achieve enhanced affinity and specificity by recognizing RNA shape and hydrogen bonding patterns.
- Designed 3D-ASOs targeting the SARS-CoV-2 frameshift stimulation element and transcription regulatory sequence.
- Identified lead 3D-ASOs that potently inhibit viral replication in human cells.
Conclusions:
- Optimized lead 3D-ASO sequences and characterized structure-activity relationships.
- Demonstrated the potential of 3D-ASO technology to combat COVID-19.
- Highlighted the broad applicability of this novel ASO design strategy for future drug development.
Related Concept Videos
siRNA - Small Interfering RNAs
In the cytoplasm, siRNA is processed from a double-stranded RNA, which comes from either endogenous DNA transcription or exogenous sources like a virus. This double-stranded RNA is then cleaved by the...
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Experimental RNAi
Structure-Activity Relationships and Drug Design
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
Types of RNA
Three main types of RNA are involved in protein synthesis: messenger RNA (mRNA), transfer RNA (tRNA), and ribosomal RNA (rRNA). These RNAs perform diverse functions and can be broadly classified as protein-coding or non-coding RNA. Non-coding RNAs play important roles in the regulation of gene expression in response to developmental and environmental changes. Non-coding RNAs in prokaryotes can be manipulated to develop more effective antibacterial drugs for human or animal use.
RNA...
Viruses with RNA Genomes

